News and Events
News and Events
You may sort news and events by title or recency. If you wish to view only news, please select the news link from the left. If you wish to see events at which Quintiles is scheduled to participate, please select the events link from the left.
- Sort by: Most Recent
- Title
-
QUINTILES COMPLETES ACQUISITION OF PHARMACIA'S CLINICAL DEVELOPMENT UNIT IN STOCKHOLM
December 22, 2000 - Quintiles Transnational Corp. (Nasdaq: QTRN), a global leader in pharmaceutical services, today announced the completion of its acquisition of Pharmacia Corporation's clinical development unit in Stockholm, Sweden. The previously announced transaction, which becomes effective January 1, 2001, provides for Quintiles to receive a total of $65 million of revenue over a period of four years for continued support and completion of ongoing and future Pharmacia development projects. -
QUINTILES SIGNS LETTER OF INTENT TO ACQUIRE PHARMACIA'S CLINICAL DEVELOPMENT UNIT IN STOCKHOLM
November 30, 2000 - Quintiles Transnational Corp. (Nasdaq: QTRN), a global leader in pharmaceutical services, today announced that it has signed a letter of intent with Pharmacia Corporation to negotiate a definitive agreement under which Quintiles will acquire Pharmacia's clinical development unit in Stockholm, Sweden. -
QUINTILES CEO SEES INDIA POISED FOR PIVOTAL ROLE IN GLOBAL PHARMACEUTICAL RESEARCH AND DEVELOPMENT
November 17, 2000 - India's powerful combination of expanding medical and information technology expertise is driving the country's growth as a center for global pharmaceutical research and development, said Dennis Gillings, Ph.D., Chairman and Chief Executive Officer of Quintiles Transnational Corp., the world's leading contract healthcare organization. -
QUINTILES ONCOLOGY THERAPEUTICS AND ASSOCIATION OF COMMUNITY CANCER CENTERS FORM EXCLUSIVE COLLABORATION
January 11, 2000 - Quintiles Oncology Therapeutics and the Association of Community Cancer Centers (ACCC) have signed a collaboration agreement granting Quintiles Oncology Therapeutics exclusive rights within the contract research industry to use and promote the central clinical research capabilities of the association's Collaborative Research Group, ACCC and Quintiles Transnational Corp. (Nasdaq: QTRN) announced today. -
QUINTILES ANNOUNCES NEW OPERATING STRUCTURE AND EXECUTIVE APPOINTMENTS
January 10, 2000 - Quintiles Transnational Corp. (Nasdaq: QTRN) today announced a change in its operating structure to enhance customer focus and efficiency.
Page 1 of 1 (5 items)